Abstract
The mannitol test was developed as an easy-to-use, safe, standardized bronchial challenge test for diagnosing asthma in a wide range of clinical settings. The mannitol test has a moderate sensitivity and will only detect approximately 60% of asthma cases. Hence, a negative mannitol test cannot be used to rule out asthma. The advantage of the mannitol test is a high specificity. In an individual with symptoms suggestive of asthma, a positive test indicates a high likelihood of asthma with ongoing airway inflammation and seems useful for detecting asthma requiring regular anti-inflammatory therapy. In this review, the current knowledge on the usefulness of the mannitol in a clinical setting as well as in clinical trials is presented and outstanding questions on the usefulness of the test are discussed.
Original language | English |
---|---|
Journal | Expert Review of Respiratory Medicine |
Volume | 7 |
Issue number | 6 |
Pages (from-to) | 655-663 |
Number of pages | 9 |
ISSN | 1747-6348 |
DOIs | |
Publication status | Published - 2013 |